Bitfount, a London, UK-based federated AI platform for clinical research, has raised $8 million in Series A funding. 

Investors 

The round included participation from Parkwalk Advisors, Ahren Innovation Capital, Pace Ventures, Foresight Group, and Portfolio Ventures. 

Bitfount Use of Funds 

The company will use the funding to accelerate product development, grow partnerships with pharmaceutical companies and CROs, and expand its platform to support the full clinical research lifecycle. 

About Bitfount 

Founded in 2020 by Dr. Blaise Thomson and Dr. Naaman Tammuz, Bitfount is a federated AI platform that enables secure, privacy-preserving collaboration on sensitive healthcare data. Designed for clinical research, the platform allows hospitals, pharmaceutical companies, and research institutions to analyze data across multiple locations without ever sharing raw patient information. Headquartered in London, United Kingdom, Bitfount’s goal is to make the world’s intractable data interactable. 

Funding Details 

Company: Bitfount Ltd. 

Raised: $8.0M 

Round: Series A 

Funding Date: July 2025 

Investors: Parkwalk Advisors, Ahren Innovation Capital, Pace Ventures, Foresight Group, Portfolio Ventures 

Company Website: https://www.bitfount.com/  

Software Category: Federated AI / HealthTech / Clinical Research Software 

Source: https://tech.eu/2025/07/23/bitfount-raises-8m-to-unlock-clinical-research-data-with-federated-ai/